Equities

OptiBiotix Health PLC

OPTI:LSE

OptiBiotix Health PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)7.65
  • Today's Change0.00 / 0.00%
  • Shares traded232.82k
  • 1 Year change-51.43%
  • Beta3.1358
Data delayed at least 20 minutes, as of Feb 06 2026 15:44 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year OptiBiotix Health PLC grew revenues 35.09% from 644.00k to 870.00k while net income improved from a loss of 2.04m to a smaller loss of 1.81m.
Gross margin45.44%
Net profit margin-16.59%
Operating margin-229.11%
Return on assets-2.22%
Return on equity-2.42%
Return on investment-2.33%
More ▼

Cash flow in GBPView more

In 2024, OptiBiotix Health PLC increased its cash reserves by 16.38%, or 104.00k. Cash Flow from Financing totalled 1.29m or 147.70% of revenues. In addition the company used 1.77m for operations while cash from investing totalled 587.00k.
Cash flow per share0.0001
Price/Cash flow per share564.46
Book value per share0.0815
Tangible book value per share0.0717
More ▼

Balance sheet in GBPView more

OptiBiotix Health PLC has little financial risk as the capital structure does not rely on leverage.
Current ratio4.61
Quick ratio3.75
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in GBP

Year on year, growth in earnings per share excluding extraordinary items increased 18.44%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		94.41
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.